Risk factors | N | HR (95% CI) a | P value |
---|---|---|---|
Baseline characteristics | |||
Age (y) | |||
< 50 | 20 | 1.000 | |
50–64 | 25 | 1.06 (0.51–2.19) | 0.89 |
≥ 65 | 79 | 1.48 (0.81–2.69) | 0.20 |
Male sex | 90 | 1.05 (0.66–1.66) | 0.85 |
Stroke | 16 | 1.09 (0.60–1.95) | 0.78 |
Smoking b | 31 | 1.18 (0.73–1.90) | 0.51 |
Hypertension | 66 | 1.09 (0.72–1.64) | 0.69 |
Coronary heart disease | 27 | 0.87 (0.54–1.40) | 0.56 |
NYHA functional classification | |||
I + II | 97 | 1.000 | |
III + IV | 27 | 1.01 (0.62–1.66) | 0.97 |
Diabetes | 24 | 1.13 (0.89–1.44) | 0.33 |
Cancer diagnosis | 44 | 1.20 (0.98–1.48) | 0.08 |
Location of surgery | |||
Others c | 39 | 1.000 | |
Intra-thoracic/abdominal | 85 | 1.73 (1.08–2.78) | 0.02 |
SOFA score on ICU admission | 124 | 1.09 (1.01–1.16) | 0.02 |
APACHE II score on ICU admission | 124 | 1.03 (1.00–1.06) | 0.037 |
Situation on the 21st day of MV | |||
No tracheostomy | 31 | 2.67 (1.70–4.17) | < 0.001 |
Consciousness (GCS = 15) | 74 | 0.79 (0.52–1.20) | 0.27 |
MDR/XDR bacterial infection | 63 | 1.53 (1.02–2.32) | 0.042 |
Intolerance of enteral nutrition d | 43 | 1.90 (1.25–2.90) | < 0.01 |
Platelet ≤150 × 109/L | 49 | 1.97 (1.30–2.97) | < 0.01 |
On vasopressors | 41 | 1.70 (1.11–2.61) | 0.02 |
On renal replacement therapy | 24 | 1.59 (0.97–2.61) | 0.068 |